|
|
||||||||
RI Subunits: A New Regulatory Step in the Fc
RI Signaling Cascade Revealed by Studies of Fc
RI Dimer Signaling Activity1





*
Departamento de Inmunologia, Instituto de Investigaciones Biomedicas, Universidad Nacional Autónoma de Mexico, Mexico City, Mexico; and
Department of Pathology and Cancer Research and Treatment Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131
Cross-linking the heterotrimeric (
ß
2) IgE receptor,
Fc
RI, of mast cells activates two tyrosine kinases: Lyn, which
phosphorylates ß and
subunit immunoreceptor tyrosine-based
activation motifs, and Syk, which binds
-phospho-immunoreceptor
tyrosine-based activation motifs and initiates cellular responses. We
studied three Fc
RI-dimerizing mAbs that maintain similar dispersed
distributions over the surface of RBL-2H3 mast cells but elicit very
different signaling responses. Specifically, mAb H10 receptor dimers
induce very little inositol 1,4,5-trisphosphate synthesis,
Ca2+ mobilization, secretion, spreading, ruffling, and
actin plaque assembly, whereas dimers generated with the other
anti-Fc
RI mAbs induce responses that are only modestly lower
than that to multivalent Ag. H10 receptor dimers activate Lyn and
support Fc
RI ß and
subunit phosphorylation but are poor Syk
activators compared with Ag and the other anti-Fc
RI mAbs. H10
receptor dimers have two other distinguishing features. First, they
induce stable complexes between activated Lyn and receptor subunits.
Second, the predominant Lyn-binding phospho-ß isoform found in mAb
H10-treated cells is a less tyrosine phosphorylated, more
electrophoretically mobile species than the predominant isoform in
Ag-treated cells that does not coprecipitate with Lyn. These studies
implicate Lyn dissociation from highly phosphorylated receptor subunits
as a new regulatory step in the Fc
RI signaling cascade required for
Syk activation and signal progression.
This article has been cited by other articles:
![]() |
A. M. Davey, K. M. Krise, E. D. Sheets, and A. A. Heikal Molecular Perspective of Antigen-mediated Mast Cell Signaling J. Biol. Chem., March 14, 2008; 283(11): 7117 - 7127. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Urtz, A. Olivera, E. Bofill-Cardona, R. Csonga, A. Billich, D. Mechtcheriakova, F. Bornancin, M. Woisetschlager, J. Rivera, and T. Baumruker Early Activation of Sphingosine Kinase in Mast Cells and Recruitment to Fc{varepsilon}RI Are Mediated by Its Interaction with Lyn Kinase Mol. Cell. Biol., October 1, 2004; 24(19): 8765 - 8777. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Faeder, W. S. Hlavacek, I. Reischl, M. L. Blinov, H. Metzger, A. Redondo, C. Wofsy, and B. Goldstein Investigation of Early Events in Fc{epsilon}RI-Mediated Signaling Using a Detailed Mathematical Model J. Immunol., April 1, 2003; 170(7): 3769 - 3781. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Strzelecka-Kiliszek, K. Kwiatkowska, and A. Sobota Lyn and Syk Kinases Are Sequentially Engaged in Phagocytosis Mediated by Fc{gamma}R J. Immunol., December 15, 2002; 169(12): 6787 - 6794. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Paar, N. T. Harris, D. Holowka, and B. Baird Bivalent Ligands with Rigid Double-Stranded DNA Spacers Reveal Structural Constraints on Signaling by Fc{epsilon}RI J. Immunol., July 15, 2002; 169(2): 856 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tolar, R. Arudchandran, L. Draberova, J. Rivera, and P. Draber Structure-Function Analysis of Lyn Kinase Association with Lipid Rafts and Initiation of Early Signaling Events after Fcvarepsilon Receptor I Aggregation Mol. Cell. Biol., December 15, 2001; 21(24): 8318 - 8328. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lara, E. Ortega, I. Pecht, J. R. Pfeiffer, A. M. Martinez, R. J. Lee, Z. Surviladze, B. S. Wilson, and J. M. Oliver Overcoming the Signaling Defect of Lyn-Sequestering, Signal-Curtailing Fc{epsilon}RI Dimers: Aggregated Dimers Can Dissociate from Lyn and Form Signaling Complexes with Syk J. Immunol., October 15, 2001; 167(8): 4329 - 4337. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |